Skip to main navigation
Skip to main content
Dice Logo
  • About
  • Approach
  • Pipeline
  • Patients
  • Investors
  • Careers

Unlocking the potential of oral medicines

Creating massive opportunities through the development of high-impact oral small molecule medicines for chronic autoimmune and inflammatory diseases.

About Us
  • Investors |
  • Overview

Investors


Investor Relations

  • Overview
  • News and Events
    • News Releases
    • Events
  • Corporate Presentation
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
  • Financial Information
    • SEC Filings
    • Annual Reports & Proxy
  • Investor Resources

Common Stock

Jun 7, 2023 12:12 PM EDT

Data Provided by Refinitiv.

Minimum 15 minutes delayed.




Learn About Stock

Latest News

May 11, 2023

DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights

May 03, 2023

DICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference

Mar 23, 2023

DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
View All News

DICE Corporate
Presentation

Latest Events

May 10, 2023 |   6:00 PM EDT

Bank of America Securities 2023 Healthcare Conference

Mar 30, 2023 |   4:00 PM EDT

H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
View All Events

Contact Us

investors@dicetx.com

Subscribe to Investor Email Alerts

Get new updates directly to your inbox

Subscribe
Dice logo
  • Careers
  • News
  • Contact Us
  • Privacy Policy
  • Terms of Use
400 East Jamie Court
Suite 300
South San Francisco
CA 94080
DICE Therapeutics ©2023
LinkedIn logo